GeoVax_logo_tag_Reg.jpg 

GeoVax Labs, Inc.
1900 Lake Park Drive, Suite 380
Smyrna, GA 30080

https://www.geovax.com/

You Might Also Like...

Key Points About GeoVax

Recent News Releases

GeoVax Labs, Inc. (GOVX-NASDAQ)

GeoVax Labs, Inc. (“GeoVax” or “the Company”) is a clinical-stage biotechnology company developing preventive and therapeutic human vaccines against infectious diseases and cancer. The Company’s proprietary GV-MVA-VLP™ vector vaccine technology utilizes a Modified Vaccinia Ankara (MVA) vector, a large virus capable of carrying several vaccine antigens, that are expressed as non-infectious virus-like particles (VLPs) in the individual receiving the vaccine (in vivo). VLPs mimic a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection through durable immune responses. GeoVax is capitalizing on the safety and efficacy of its technology platform to address the urgent need for a COVID-19 vaccine and is also developing vaccines against human immunodeficiency virus (HIV), Zika virus (ZIKV), hemorrhagic fever (HF) viruses (Ebola, Sudan, Marburg, and Lassa Fever) and malaria. Furthermore, the Company is applying its MVA-VLP technology to cancer immunotherapy (immuno-oncology).

* The Corporate Snapshot was last updated on September 21, 2020.


 

Latest Research

GOVX_COVER_PG_10-22-2020

 

NEW REPORT

Download GeoVax Labs, Inc.  Updated Base Report 10-21-2020

 

 

 


Past Research

GOVX_COVER_PG_11-11-2020

Download Update

NEW UPDATE!

11-11-20

 


Cover Image Update 05-28-19

Download Update

05-28-19


Cover Image Update 04-01-19

Download Update

04-01-2019


Cover Image Update 11-14-18

 Download Update

11-14-2018


Cover Image Update 08-14-18_jpg

Download Update

  08-14-2018


GeoVax_Update_Cover_image_03-01-18

Download Update

03-01-2018


GeoVax-Quarterly-Update-Image_10-18-17.png

Download Update

10-18-2017


GeoVax_EIO_Cover_Image_1.png

Download GeoVax Report

06-15-2017


Key Points About GeoVax

Blogs: GOVX